United States Hematology Market Outlook to 2024
Summary
GlobalData’s new report, United States Hematology Market Outlook to 2024, provides key market data on the United States Hematology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Hematology Analyzers, Hematology Cell Counters, Hematology Rapid Tests & POC, Hematology Reagents, Hemostasis and Immunohematology
The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.
Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.
Scope
- Market size and company share data for Hematology market segments - Hematology Analyzers, Hematology Cell Counters, Hematology Rapid Tests & POC, Hematology Reagents, Hemostasis and Immunohematology.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Hematology market.
- Key players covered include F. Hoffmann-La Roche Ltd, Beckman Coulter Inc and Abbott Laboratories.
- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
- 1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Hematology Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
- 3 Hematology Market, United States
- 3.1 Hematology Market, United States, Revenue ($m), 2010-2017
- 3.2 Hematology Market, United States, Revenue ($m), 2017-2024
- 3.3 Hematology Market, United States, Volume (Units), 2010-2017
- 3.4 Hematology Market, United States, Volume (Units), 2017-2024
- 3.5 Hematology Market, United States, Average Price ($), 2010-2024
- 3.6 Hematology Market, United States, Distribution Share by Revenue ($m), 2017
- 3.7 Hematology Market, United States, Company Share by Revenue ($m), 2017
- 4 Overview of Key Companies in United States, Hematology Market
- 4.1 Sysmex Corp
- 4.2 F. Hoffmann-La Roche Ltd
- 4.3 Beckman Coulter Inc
- 4.4 Abbott Laboratories
- 4.5 Siemens Healthcare GmbH
- 4.6 Instrumentation Laboratory Company
- 4.7 Thermo Fisher Scientific Inc
- 4.8 Sigma-Aldrich Corp
- 4.9 Sekisui Diagnostics LLC
- 4.10 Bio-Rad Laboratories Inc
- 4.11 Becton Dickinson and Co
- 5 Hematology Market Pipeline Products
- 6 Financial Deals Landscape
- 6.1 Asset Transactions
- 6.2 Debt Offerings
- 6.3 Equity Offerings
- 6.4 Merger
- 6.5 Partnerships
- 6.6 Private Equity
- 6.7 Venture Financing
- 7 Recent Developments
- 7.1 Corporate Communications
- 7.2 Financial Announcements
- 7.3 Government and Public Interest
- 7.4 Legal And Regulatory
- 7.5 Other Significant Developments
- 7.6 Product News
- 7.7 Research And Development
- 7.8 Strategy And Business Planning
- 8 Appendix
- 8.1 Research Methodology
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
- 1.1 List of Tables
- Table 1: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 2: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 3: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 4: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 5: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 6: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 7: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 8: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Table 9: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 10: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 11: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 12: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 13: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 14: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Table 15: Hematology Market, United States, Volume (Units), Historic, 2010-2017
- Table 16: Hematology Market, United States, Volume (Units), Forecast, 2017-2024
- Table 17: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017
- Table 18: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
- Table 19: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017
- Table 20: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017
- Table 21: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024
- Table 22: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
- Table 23: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024
- Table 24: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024
- Table 25: Hematology Market, United States, Average Price ($) Historic, 2010-2017
- Table 26: Hematology Market, United States, Average Price ($), Forecast, 2017-2024
- Table 27: Hematology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
- Table 28: Hematology Market, United States, Company Share by Revenue ($m), USD Constant, 2017
- Table 29: Hematology Market Pipeline Products
- Table 30: Polymedco Acquires US Distribution Rights to PATHFAST Product Line from LSI Medience
- Table 31: Rosetta Genomics Raises USD2 Million in Private Placement of Debentures and Warrants
- Table 32: Rennova Health to Raise USD2.1 Million in Private Placement of Debentures and Warrants
- Table 33: LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024
- Table 34: LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027
- Table 35: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019
- Table 36: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020
- Table 37: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022
- Table 38: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022
- Table 39: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024
- Table 40: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027
- Table 41: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047
- Table 42: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019
- Table 43: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million
- Table 44: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million
- Table 45: Vermillion Plans to Raise up to USD50 Million in Public Offering of Securities
- Table 46: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares
- Table 47: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares
- Table 48: Vermillion Plans to Raise up to USD6.8 in Public Offering of Shares
- Table 49: Vermillion Raises USD5.2 Million in Private Placement of Shares and Warrants
- Table 50: Aviragen Therapeutics to Merge with Vaxart
- Table 51: Grail to Merge with Cirina
- Table 52: Genoptix and Bionano Genomics Enter into Co-Development Agreement
- Table 53: Grifols and Beckman Coulter Enter into Distribution Agreement
- Table 54: Aferetica Enters into Partnership with CytoSorbents
- Table 55: Sophia Genetics Enters into Agreement with ArcherDx
- Table 56: Avista Capital Partners to Acquire Miraca Life Sciences from Miraca Holdings
- Table 57: SenGenix Raises USD6.3 Million in Financing
- Table 58: VentureMed Group Raises USD15 Million in Series B Financing
- Table 59: Magnolia Medical Tech Raises Additional USD7.3 Million in Series B Financing
- Table 60: Bioptix Raises USD2.3 Million in Venture Financing
- Table 61: Exactus Raises Funds through Venture Financing
- Table 62: Protege Biomedical Raises USD0.3 Million in Venture Financing
- Table 63: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
- 1.2 List of Figures
- Figure 1: Hematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 2: Hematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 3: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 4: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 5: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 6: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 7: Hemostasis Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 8: Immunohematology Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
- Figure 9: Hematology Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 10: Hematology Cell Counters Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 11: Hematology Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 12: Hematology Reagents Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 13: Hemostasis Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 14: Immunohematology Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
- Figure 15: Hematology Market, United States, Volume (Units), Historic, 2010-2017
- Figure 16: Hematology Market, United States, Volume (Units), Forecast, 2017-2024
- Figure 17: Hematology Analyzers Market, United States, Volume (Units), Historic, 2010-2017
- Figure 18: Hematology Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017
- Figure 19: Hematology Reagents Market, United States, Volume (Units), Historic, 2010-2017
- Figure 20: Hemostasis Market, United States, Volume (Units), Historic, 2010-2017
- Figure 21: Hematology Analyzers Market, United States, Volume (Units), Forecast, 2017-2024
- Figure 22: Hematology Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024
- Figure 23: Hematology Reagents Market, United States, Volume (Units), Forecast, 2017-2024
- Figure 24: Hemostasis Market, United States, Volume (Units), Forecast, 2017-2024
- Figure 25: Hematology Market, United States, Company Share (%) 2017
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook